Mydecine Innovations Group Inc. announced that John Ross, the company?s current chief financial officer has been appointed as corporate secretary, effective immediately. The company also announced that Mr. Todd Heinzl has resigned from the board of directors of the company, effective immediately, to pursue other endeavors. Mr. Ross is a senior financial management professional with more than 30 years of private and public company experience.

He was first appointed as the chief financial officer of the company on September 16, 2022.